CINECA IRIS Institutional Research Information System

CORSINI, GIOVANNI UMBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 17.556
NA - Nord America 17.306
AS - Asia 7.805
SA - Sud America 905
AF - Africa 253
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 5
Totale 43.845
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.558
FI - Finlandia 7.754
PL - Polonia 4.307
CA - Canada 2.645
CN - Cina 2.487
SG - Singapore 2.323
IT - Italia 1.490
SE - Svezia 1.005
HK - Hong Kong 932
GB - Regno Unito 773
BR - Brasile 742
KR - Corea 550
VN - Vietnam 531
BG - Bulgaria 495
UA - Ucraina 460
DE - Germania 427
TR - Turchia 346
FR - Francia 250
RU - Federazione Russa 236
CH - Svizzera 176
IN - India 160
JP - Giappone 107
BD - Bangladesh 96
CI - Costa d'Avorio 81
AR - Argentina 54
IQ - Iraq 44
MX - Messico 38
SA - Arabia Saudita 35
ZA - Sudafrica 34
BE - Belgio 32
VE - Venezuela 32
PK - Pakistan 26
SN - Senegal 26
NL - Olanda 25
EC - Ecuador 23
KE - Kenya 23
UZ - Uzbekistan 23
ES - Italia 22
MA - Marocco 19
TN - Tunisia 16
AT - Austria 15
IL - Israele 14
AE - Emirati Arabi Uniti 13
CO - Colombia 13
GR - Grecia 13
ID - Indonesia 13
JM - Giamaica 13
JO - Giordania 13
BB - Barbados 11
CZ - Repubblica Ceca 11
MY - Malesia 11
NG - Nigeria 11
IE - Irlanda 10
KZ - Kazakistan 10
PY - Paraguay 10
QA - Qatar 10
TT - Trinidad e Tobago 10
UY - Uruguay 10
AL - Albania 9
CR - Costa Rica 9
BJ - Benin 8
NP - Nepal 8
PE - Perù 8
AU - Australia 7
AZ - Azerbaigian 7
CL - Cile 7
DZ - Algeria 7
EG - Egitto 7
NZ - Nuova Zelanda 7
OM - Oman 7
PH - Filippine 7
HU - Ungheria 6
LB - Libano 6
PT - Portogallo 6
EE - Estonia 5
ET - Etiopia 4
HN - Honduras 4
MD - Moldavia 4
RO - Romania 4
BO - Bolivia 3
BY - Bielorussia 3
EU - Europa 3
KG - Kirghizistan 3
LT - Lituania 3
LV - Lettonia 3
PS - Palestinian Territory 3
SY - Repubblica araba siriana 3
AG - Antigua e Barbuda 2
AM - Armenia 2
BF - Burkina Faso 2
BS - Bahamas 2
BW - Botswana 2
BZ - Belize 2
GE - Georgia 2
GH - Ghana 2
HR - Croazia 2
JE - Jersey 2
LY - Libia 2
NI - Nicaragua 2
PA - Panama 2
Totale 43.801
Salva come PNG Salva come JPEG
Città #
Helsinki 7.480
Montreal 2.306
Ashburn 1.428
Woodbridge 1.390
Singapore 1.368
Fairfield 1.177
Ann Arbor 1.081
Houston 1.010
Chandler 947
Hong Kong 919
Hefei 746
San Jose 694
Santa Clara 690
Jacksonville 590
Milan 554
Seoul 540
Seattle 534
Dallas 501
Sofia 494
Cambridge 420
Wilmington 410
Beijing 407
Lancaster 391
Shanghai 369
New York 308
Ottawa 286
Izmir 227
Los Angeles 217
Boardman 206
Nanjing 196
Princeton 193
Lawrence 187
Medford 172
Lauterbourg 170
Bern 157
Serra 132
Des Moines 131
Dearborn 128
Buffalo 125
Jüchen 100
Ho Chi Minh City 99
Tokyo 99
London 96
Istanbul 93
Nanchang 93
Dong Ket 88
Abidjan 81
Hanoi 78
Chicago 77
Council Bluffs 68
São Paulo 68
San Diego 56
Redondo Beach 47
Kunming 45
Ogden 45
Redwood City 45
Rome 45
Frankfurt am Main 42
Boulder 40
Columbus 35
Munich 35
Brussels 32
The Dalles 32
Norwalk 30
Florence 29
Pune 29
Shenyang 27
Bremen 26
Changsha 26
Dakar 26
Düsseldorf 26
Rio de Janeiro 26
Hebei 25
Tianjin 23
Falls Church 22
Tashkent 22
Dhaka 21
Nairobi 21
Verona 21
Phoenix 19
Da Nang 18
Guangzhou 18
Jiaxing 18
Orange 18
Turku 18
Orem 17
Zurich 17
Riyadh 16
Belo Horizonte 15
Baghdad 14
Paris 14
Washington 14
Amman 13
Fuzhou 13
Grafing 13
Haiphong 13
Johannesburg 13
Mumbai 13
Pisa 12
San Francisco 12
Totale 31.538
Salva come PNG Salva come JPEG
Nome #
Parkinsonism by MPTP in mice: a model for regenerative processes of nigrostriatal dopaminergic pathway 5.315
MPTP FAILS TO INDUCE LIPID-PEROXIDATION INVIVO 3.952
PARKINSONS-DISEASE AND PESTICIDES 3.050
HIGH-AFFINITY BINDING-SITES FOR 1-METHYL-4-PHENYL-PYRIDINIUM ION (MPP+) ARE PRESENT IN MOUSE-BRAIN 2.395
[H-3] 1-METHYL-4-PHENYL-2,3-DIHYDROPYRIDINIUM ION BINDING-SITES IN MOUSE-BRAIN - PHARMACOLOGICAL AND BIOLOGICAL CHARACTERIZATION 253
G protein-linked receptors: pharmacological evidence for the formation of heterodimers 249
Pharmacological manipulation of embryonic dopaminergic neurons implanted in adult mouse striatum: a new therapeutical approach to Parkinson’s disease. 247
Characterization of the Engrailed mutant mice as experimental models for Parkinson's disease 245
Partial agonist actions at dopamine D2L receptors are modified by co-transfection of D3 receptors: potential role of heterodimer formation 236
Fluorescent light induces neurodegeneration in the rodent nigrostriatal system but near infrared LED light does not 236
Embryonic neural grafts induce recovery in mice with permanent striatal lesion 229
Localization of a glutathione-dependent dehydroascorbate reductase within the central nervous system of the rat 229
D-1 AND D-2 DOPAMINE SYSTEM INTERACTIONS IN THE MPTP-LESIONED MONKEY 226
(+)MK-801 PREVENTS THE DDC-INDUCED ENHANCEMENT OF MPTP TOXICITY IN MICE 226
Ethanol intake and ethanol-induced locomotion and locomotor sensitization in CYP2E1 knockout mice 225
Bright light exposure reduces TH-positive dopamine neurons: implications of light pollution in Parkinson's disease epidemiology. 224
Cytochrome P450 and Parkinson's disease: protective role of neuronal CYP 2E1 from MPTP toxicity 216
Clozapine as the most efficacious antipsychotic for activating ERK 1/2 kinases: Role of 5-HT2A receptor agonism 213
Pharmacological modulation of regenerative processes aftar nigrostriatal dopaminergic lesion: a new therapeutical approach to Parkinson’s disease 212
Region- and neurotransmitter-dependent species and strain differences in DSP-4-induced monoamine depletion in rodents. 211
Involvement of cytochrome P450 2E1 in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease 210
Assessing neuroprotection in Parkinson's disease: from the animal models to molecular neuroimaging in vivo 209
INCREASED PAROXYSMAL ACTIVITY OF PARTIAL SEIZURES IN MAN BY APOMORPHINE 208
Apomorphine offers new insight into dopaminergic neuron vulnerability in mesencephalic cultures 208
PHARMACOLOGICAL MANIPULATION OF EMBRYONIC DOPAMINERGIC-NEURONS IMPLANTED IN ADULT-MOUSE STRIATUM - A NEW THERAPEUTIC APPROACH TO PARKINSONS-DISEASE 206
1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE - CORRESPONDENCE OF ITS BINDING-SITES TO MONOAMINE-OXIDASE IN RAT-BRAIN, AND INHIBITION OF DOPAMINE OXIDATIVE DEAMINATION INVIVO AND INVITRO 203
HIGH-AFFINITY BINDING OF [H-1]1-METHYL-4-PHENYL-2,3-DIHYDROPYRIDINIUM ION TO MOUSE STRIATAL MEMBRANES - PUTATIVE VESICULAR LOCATION 203
Clonidine prevents while yohimbine enhances MPTP toxicity in mice. 203
Partial agonist actions of aripiprazole and the candidate antipsychotics S33592, bifeprunox, N-desmethylclozapine and preclamol at dopamine D(2L) receptors are modified by co-transfection of D(3) receptors: potential role of heterodimer formation 203
Revealing G-protein-coupled receptor oligomerization at the single-molecule level through a nanoscopic lens: Methods, dynamics and biological function 203
EVIDENCE FOR DOPAMINE RECEPTORS IN HUMAN-BRAIN MEDIATING SEDATION AND SLEEP 202
Serotonin abnormalities in engrailed-2 knockout mice: new insight relevant for a model of autism spectrum disorder 202
Acetaldehyde and parkinsonism: role of CYP450 2E1. 201
COVALENT BINDING AS A BIOCHEMICAL MECHANISM FOR TOXICITIES COVALENT BINDING OF STILBENE (ST) AND DIETHYLSTILBESTROL (DES) TO LIVER-MICROSOMES 200
DEPRENYL SELECTIVELY INHIBITS [H-3] MPTP BINDING-SITES IN MONKEY BRAIN 199
TSH-Dependent Expression of the LDL Receptor-Associated Protein (RAP) in Thyroid Epithelial Cells 198
MPTP-induced model of Parkinson's disease in cytochrome P450 2E1 knockout mice 198
Pharmacologic modulation of MPTP toxicity: MK 801 in prevention of dopaminergic cell death in monkeys and mice. 197
Molecular targets of atypical antipsychotics: From mechanism of action to clinical differences 197
Role of CYP2E1 in the mouse model of MPTP toxicity 194
MK-801 prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in primates. 194
Behavioral, Neurochemical, and Electrophysiological Changes in an Early Spontaneous Mouse Model of Nigrostriatal Degeneration 194
EFFECTS OF BIGUANIDES ON FATTY-ACID AND GLUCOSE OXIDATION IN MUSCLE 193
APOMORPHINE HYDROCHLORIDE-INDUCED IMPROVEMENT IN HUNTINGTONS-CHOREA - STIMULATION OF DOPAMINE RECEPTOR 193
INHIBITION OF [H-3] MPTP BINDING TO RAT-BRAIN BY PARGYLINE 193
SELECTIVE INCREASE OF BRAIN DOPAMINE SYNTHESIS BY SULPIRIDE 189
CYP 2E1 mutant mice are resistant to DDC-induced enhancement of MPTP toxicity 189
Sodium nitroprusside induces internalization of muscarinic receptors stably expressed in Chinese hamster ovary cell lines 188
MPTP TREATMENT COMBINED WITH ETHANOL OR ACETALDEHYDE SELECTIVELY DESTROYS DOPAMINERGIC-NEURONS IN MOUSE SUBSTANTIA NIGRA 187
Identification and determination of 3,4-dihydroxyphenylacetaldehyde, the dopamine metabolite in in vivo dialysate from rat striatum. 187
Increased susceptibility to kainic acid-induced seizures in Engrailed-2 knockout mice. 186
Effects of Pretreatment with N-(2-Chloroethyl)-N- Ethyl-2-Bromobenzylamine (DSP-4) of Methamphetamine Pharmacokinetics and Striatal Dopamine losses 185
DECREASED CONVERSION OF TYROSINE TO CATECHOLAMINES IN BRAIN OF RATS TREATED WITH PARA CHLOROPHENYLALANINE 184
METOCLOPRAMIDE AND DYSTONIC REACTIONS IN SARDINIANS 184
Nicotine prevents experimental parkinsonism in rodents and induces striatal increase of neurotrophic factors. 184
Functional role of the third cytoplasmic loop in muscarinic receptor dimerization. 183
Modulation of dihydroxyphenylacetaldehyde extracellular levels in vivo in the rat striatum after different kinds of pharmacological treatment 182
Effect of metadoxine on striatal dopamine levels in C57 black mice 181
THERAPEUTIC EFFICACY OF APOMORPHINE COMBINED WITH AN EXTRA-CEREBRAL INHIBITOR OF DOPAMINE RECEPTORS IN PARKINSONS-DISEASE 180
DOMPERIDONE AND APOMORPHINE IN HUNTINGTONS-CHOREA 179
DOPAMINERGIC MECHANISMS IN HEMIPARKINSONIAN MONKEYS 179
ACETALDEHYDE DIRECTLY ENHANCES MPP+ NEUROTOXICITY AND DELAYS ITS ELIMINATION FROM THE STRIATUM 179
SPECIFIC REINNERVATION OF LESIONED MOUSE STRIATUM BY GRAFTED MESENCEPHALIC DOPAMINERGIC-NEURONS 179
From dopamine metabolism to Parkinson’s disease. 179
Pharmacological modulation of regenerative processes after nigrostriatal dopaminergic lesion: A new therapeutical approach to Parkinson's disease 179
Apomorphine has a potent antiproliferative effect on Chinese hamster ovary cells 179
EFFECT OF ORAL-ADMINISTRATION OF TRYPTOPHAN-FREE AMINO-ACID MIXTURES ON SERUM TRYPTOPHAN, BRAIN TRYPTOPHAN AND SEROTONIN METABOLISM 177
PROPERTIES OF BENZODIAZEPINE BINDING-SITES IN PERIPHERAL-TISSUES 177
Dopamine agonists and analogues have an antiproliferative effect on CHO-K1 cells 177
Long-term treatment of bipolar disorder:how should we use lithium salts? 177
EFFECT OF APOMORPHINE ON HUMAN SLEEP 175
MODULATION OF DOPAMINE AGONIST ACTION BY ESTROGENS 175
INHIBITION OF NITRIC-OXIDE SYNTHASE DRAMATICALLY POTENTIATES SEIZURES INDUCED BY KAINIC ACID AND PILOCARPINE IN RATS 173
DOPAMINE AGONISTS IN THE TREATMENT OF SCHIZOPHRENIA 170
Biochemestry of experimental parkinsonism. 170
PHARMACOLOGICAL MODULATION OF DEVELOPMENT AND PLASTICITY IN NIGRO-STRIATAL DOPAMINERGIC-NEURONS 170
PARKINSONISM BY HALOPERIDOL AND PIRIBEDIL 169
Nicotine prevents experimental parkinsonism in rodents. 169
An unusual form of the association binding kinetics of N-[ [H-3] methylscopolamine to the split muscarinic M-2trunk/M-2tail receptor 168
Norepinephrine loss selectively enhances chronic nigrostriatal dopamine depletion in mice and rats 167
CHARACTERIZATION OF A PUTATIVELY VESICULAR BINDING-SITE FOR [H-3] MPP+ IN MOUSE STRIATAL MEMBRANES 166
Striatal increase of neurotrophic factors as a mechanism of nicotine protection in experimental parkinsonism. 166
Mk-801 previene la degenerazione dei neuroni dopaminergici nigrostriatali indotta da MPTP: ruolo degli aminoacidi eccitatori nei processi di invecchiamento del sistema nigrostriatale. 165
Dose-dependent induction of apoptosis by R-apomorphine in CHO-K 1 cell line in culture 165
Is lithium able to reverse neurological damage induced by vinca alkaloids? 164
ROLE OF H-3 MPP+ BINDING-SITES IN THE MPTP NEUROTOXICITY USING QUANTITATIVE AUTORADIOGRAPHY 163
Norepinephrine loss exacerbates methamphetamine-induced striatal dopamine depletion in mice 163
Antagonist binding profile of the split chimeric muscarinic m2-trunc/m3-tail receptor 162
Molecular and cellular events regulating dopamine survival 162
Cytochrome p450 and parkinsonism: protective role of CYP2E1 162
TRYPTOPHAN-FREE DIETS - NEW MEANS FOR EFFECTIVELY DECREASING BRAIN-SEROTONIN SYNTHESIS IN ANIMALS AND MAN 161
Involvment of excitatory aminoacids in MPTP toxicity 160
IN BROWN-NORWAY RATS, MPP(+) IS ACCUMULATED IN THE NIGROSTRIATAL DOPAMINERGIC TERMINALS BUT IT IS NOT NEUROTOXIC - A MODEL OF NATURAL-RESISTANCE TO MPTP TOXICITY 160
Noradrenergic modulation of methamphetamine-induced striatal dopamine depletion 160
Species differences in the role of excitatory amino acids in experimental parkinsonism. 157
MK801 prevents MPTP-induced dopaminergic cell death in monkeys and mice 155
Effects of locus coeruleus lesions on development of functional propertues of rat visual cortical neurons. 155
Striatal MPP+ levels do not necessarily correlate with striatal dopamine levels after MPTP treatment in mice. 155
(+) MK-801 PREVENTS DIETHYLDITHIOCARBAMATE-INDUCED NEURONAL DAMAGE 154
BIOCHEMICAL MECHANISMS FOR HEPATOTOXICITY PRODUCED BY DIETHYLSTILBESTROL 153
Totale 32.864
Salva come PNG Salva come JPEG
Categoria #
all - tutte 94.413
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 94.413
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.059 66 106 41 155 413 269 32 96 102 73 86 620
2022/20232.469 355 354 124 241 274 359 27 184 389 12 125 25
2023/20248.729 386 212 335 124 267 369 42 74 42 6.644 43 191
2024/20256.298 32 207 37 353 534 507 403 280 498 727 823 1.897
2025/202613.117 423 1.037 825 363 384 623 1.026 222 7.613 364 154 83
2026/202727 27 0 0 0 0 0 0 0 0 0 0 0
Totale 44.077